News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
304,598 Results
Type
Article (11736)
Company Profile (10)
Press Release (292848)
Multimedia
Podcasts (35)
Webinars (6)
Section
Business (88028)
Career Advice (206)
Deals (19305)
Drug Delivery (32)
Drug Development (36823)
Employer Resources (29)
FDA (5832)
Job Trends (6041)
News (147127)
Policy (9670)
Tag
2027 Pharm Country Standard (1)
Academia (739)
Accelerated approval (32)
Adcomms (5)
Allergies (82)
Alliances (13516)
ALS (127)
Alzheimer's disease (924)
Antibody-drug conjugate (ADC) (254)
Approvals (6229)
Artificial intelligence (358)
Autoimmune disease (167)
Automation (24)
Bankruptcy (172)
Best Places to Work (5361)
BIOSECURE Act (5)
Biosimilars (123)
Biotechnology (15)
Bladder cancer (138)
Brain cancer (46)
Breast cancer (471)
Cancer (3741)
Cardiovascular disease (313)
Career advice (186)
Career pathing (4)
CAR-T (166)
CDC (16)
Cell therapy (475)
Cervical cancer (32)
Clinical research (34516)
Collaboration (1151)
Company closure (4)
Compensation (504)
Complete response letters (30)
COVID-19 (732)
CRISPR (59)
C-suite (645)
Cystic fibrosis (99)
Data (5082)
Decentralized trials (1)
Denatured (11)
Depression (80)
Dermatology (43)
Diabetes (302)
Diagnostics (2920)
Digital health (28)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (164)
Drug pricing (67)
Drug shortages (10)
Duchenne muscular dystrophy (181)
Earnings (55107)
Editorial (40)
Employer branding (5)
Employer resources (26)
Events (60611)
Executive appointments (700)
FDA (8077)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (10)
Frontotemporal dementia (20)
Funding (1318)
Gene editing (123)
Generative AI (22)
Gene therapy (379)
GLP-1 (512)
Government (1259)
Grass and pollen (4)
Guidances (355)
Healthcare (7791)
HIV (62)
Huntington's disease (26)
IgA nephropathy (66)
Immunology and inflammation (160)
Immuno-oncology (63)
Indications (101)
Infectious disease (902)
Inflammatory bowel disease (124)
Inflation Reduction Act (10)
Influenza (56)
Intellectual property (154)
Interviews (30)
IPO (11413)
IRA (14)
Job creations (993)
Job search strategy (159)
JPM (59)
Kidney cancer (15)
Labor market (22)
Layoffs (160)
Leadership (10)
Legal (1760)
Liver cancer (67)
Longevity (10)
Lung cancer (585)
Lymphoma (277)
Machine learning (34)
Management (8)
Manufacturing (518)
MASH (125)
Medical device (6144)
Medtech (6184)
Mergers & acquisitions (8866)
Metabolic disorders (823)
mRNA (79)
Multiple sclerosis (110)
NASH (15)
Neurodegenerative disease (240)
Neuropsychiatric disorders (56)
Neuroscience (1788)
Neurotech (1)
NextGen: Class of 2026 (2480)
Non-profit (1186)
Now hiring (9)
Obesity (375)
Opinion (100)
Ovarian cancer (112)
Pain (135)
Pancreatic cancer (191)
Parkinson's disease (214)
Partnered (11)
Patents (270)
Patient recruitment (373)
Peanut (30)
People (21910)
Pharmaceutical (9)
Pharmacy benefit managers (9)
Phase 1 (9256)
Phase 2 (14941)
Phase 3 (12880)
Pipeline (5418)
Policy (98)
Postmarket research (1227)
Preclinical (3963)
Press Release (15)
Prostate cancer (200)
Psychedelics (16)
Radiopharmaceuticals (156)
Rare diseases (596)
Real estate (1601)
Recruiting (11)
Regulatory (9310)
Reports (13)
Research institute (752)
Resumes & cover letters (35)
Rett syndrome (27)
RNA editing (8)
RSV (42)
Schizophrenia (109)
Series A (245)
Series B (184)
Service/supplier (2)
Sickle cell disease (70)
Special edition (9)
Spinal muscular atrophy (49)
Sponsored (16)
Startups (2325)
State (1)
Stomach cancer (14)
Supply chain (61)
Tariffs (41)
The Weekly (24)
Vaccines (373)
Venture capital (102)
Weight loss (235)
Women's health (72)
Worklife (1)
Date
Today (111)
Last 7 days (388)
Last 30 days (1674)
Last 365 days (20462)
2026 (6051)
2025 (20616)
2024 (19999)
2023 (20964)
2022 (23761)
2021 (25687)
2020 (23833)
2019 (19010)
2018 (14207)
2017 (13968)
2016 (12333)
2015 (15672)
2014 (11433)
2013 (8330)
2012 (9074)
2011 (9776)
2010 (8836)
Location
Africa (183)
Alabama (41)
Alaska (2)
Arizona (128)
Arkansas (6)
Asia (16975)
Australia (2757)
California (8626)
Canada (2287)
China (793)
Colorado (376)
Connecticut (423)
Delaware (275)
Europe (38973)
Florida (1105)
Georgia (252)
Hawaii (3)
Idaho (22)
Illinois (632)
India (43)
Indiana (376)
Iowa (11)
Japan (373)
Kansas (51)
Kentucky (18)
Louisiana (27)
Maine (44)
Maryland (887)
Massachusetts (6091)
Michigan (273)
Minnesota (444)
Mississippi (4)
Missouri (113)
Montana (8)
Nebraska (7)
Nevada (104)
New Hampshire (42)
New Jersey (2353)
New Mexico (12)
New York (2180)
North Carolina (930)
North Dakota (3)
Northern California (4184)
Ohio (206)
Oklahoma (9)
Oregon (18)
Pennsylvania (1510)
Puerto Rico (10)
Rhode Island (25)
South America (333)
South Carolina (22)
Southern California (3537)
Tennessee (131)
Texas (1361)
United States (29306)
Utah (190)
Vermont (1)
Virginia (210)
Washington D.C. (30)
Washington State (694)
West Virginia (4)
Wisconsin (101)
Wyoming (2)
304,598 Results for "genstar capital l p".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
GCAR and Purdue Pharma L.P. Announce Initiation of Tinostamustine in GBM AGILE Trial
April 8, 2026
·
6 min read
Press Releases
MCI Capital Markets and AxialBridge to Deliver Integrated De-Risking and Capital Access Platform for Life Science Companies
Partnership to Provide Life Science Companies with Turnkey Solution for Award Winning Capital Market Access, Best-In-Class Regulatory Affairs Management, Clinical Trial Management Services, and Investor Engagement
March 18, 2026
·
4 min read
Press Releases
Turbett Surgical Announces Recapitalization and Growth Investment by J.P. Morgan Life Sciences Private Capital
January 28, 2026
·
3 min read
Press Releases
L7 Informatics Announces L7 SYNAPSE™: Advancing Context-Aware AI for Regulated Scientific Execution
April 9, 2026
·
1 min read
Funding
RA Capital Looks to China for Next Startup To Put on SPAC Track to Nasdaq
While RA Capital Management has yet to commit to a merger plan, it noted that its new blank-check company, Research Alliance III, could target companies abroad, including those from China.
March 25, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Digital Disruption in Life Sciences: L7 Informatics Says Competitive Advantage Will Come From Governed Execution
L7 Informatics CEO explains why the next wave of life sciences innovation depends on digital unified platforms that orchestrate workflows, contextualize data, and enable AI-actionable operations.
February 12, 2026
·
1 min read
Insights
JPM26: As Capital Concentrates, VCs Scrutinize Founder Pedigree and CEO Fit in Early Biotech
Venture funds attending the J.P. Morgan Healthcare Conference said mounting funding pressures and Chinese competition have sharpened their focus on leadership qualities, from regulatory expertise and industry experience to the ability to scale—or step aside—as companies mature.
January 15, 2026
·
2 min read
·
Jennifer C. Smith-Parker
Press Releases
Spruce Biosciences Secures Up to $50 Million in Growth Capital from Avenue Capital
January 8, 2026
·
5 min read
Press Releases
Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare Forum
March 13, 2026
·
1 min read
Press Releases
Anaergia S.r.l. Expands Scope at Three Biomethane Facilities Being Built for QGM S.á.r.l. in Italy, Increasing Contracts by C$17 Million
March 17, 2026
·
3 min read
1 of 30,460
Next
